| Business Name: |
Golubeva-Ganel Arina MD |
| Contact Person: |
Arina Golubeva-Ganel |
| Address: |
5 Harris Court Building T2, Monterey, California 93940 |
| Phone Number: |
(831) 375-4105 |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Braslau Daniel MD - Monterey, CA 93940
Barnard Isabelle MD - Monterey, CA 93940
Hell Richard W MD - Monterey, CA 93940
Garren Mary L MD - Monterey, CA 93940
Palmer James D MD - Monterey, CA 93940
Fithian III W Taylor MD - Monterey, CA 93940
King Richard E MD - Monterey, CA 93940
Lake James MD - Monterey, CA 93940
Lewis William R MD - Monterey, CA 93940
Cr Eckstein Med - Monterey, CA 93940
A B See Eye Care-Gonzalez Gust - Monterey, CA 93940
Eikenberry David J MD - Monterey, CA 93940
Brinks Heinrich MD - Monterey, CA 93940
Ko Youjong MD - Monterey, CA 93940
Physicians Hearing Service - Monterey, CA 93940
Schuller Arthur B MD - Monterey, CA 93940
Dacus James MD - Monterey, CA 93940
Levin Robert B MD - Monterey, CA 93940
Luba Daniel G MD - Monterey, CA 93940
Roux Susan MD - Monterey, CA 93940
|
The company Golubeva-Ganel Arina MD provides B2C services in the form of Doctors from its single location in California.
1 to 4 employees work for Golubeva-Ganel Arina MD, and the business now earns $500.000 to $999.999 per annum.
Golubeva-Ganel Arina MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Golubeva-Ganel Arina MD, please call Arina Golubeva-Ganel with the phone number (831) 375-4105 or visit its single location at 5 Harris Court Building T2 in Monterey, California 93940.
The location of the single location can also be found using the coordinates 36.58049,-121.81983.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.